Proteins with known 3D structures
Identification and Colliers de Perles: Human Immunoglobulins
Overview table Identification of the genes and alleles involved in the rearrangements and expressed in the variable regions Protein display of the Ig V-D-J and V-J-REGIONs

Click here to see: Part 1 - Human Ig heavy chains associated or not to a kappa or lambda chain
Click here to see: Part 2 - Human Ig kappa chains associated or not to a heavy chain

Part 3 - Human Ig lambda chains associated or not to a heavy chain
Reference of this table: Ruiz, M. and Lefranc, M.-P., Immunogenetics, 53, 857-883 (2002) PMID:11862387, LIGM:259

Updates from 09/05/2001 are available in IMGT/3Dstructure-DB. IMGT/3Dstructure-DB entries (cards) are identified by the PDB code.
Click on a PDB code to get the corresponding IMGT/3Dstructure-DB card.
Click on a PDB chain name to get the corresponding Protein display.
Click on the CDR-IMGT lengths to get the corresponding Collier de Perles.

The gene identification was automatically determined by comparing PDB amino acid sequences with the IMGT reference directory translated sequences, using the stand-alone BLAST program.

Protein name  PDB code Heavy chain Lambda chain
PDB chain name IGH V-D-J-REGION IGH C-REGION PDB chain name IGL V-J-REGION IGL C-REGION
IGHV gene and allele name IGHD gene and allele name IGHJ gene and allele name CDR-IMGT lengths IGHC gene name Exons IGLV gene and allele name IGLJ gene and allele name CDR-IMGT lengths IGLC gene name
B7-15A2 1aqk H IGHV3-30*01 or IGHV3-30*04 or IGHV3-30*07 or IGHV3-30*11 or IGHV3-30*14 or IGHV3-30*16 or IGHV3-30*17 or IGHV3-30-3*01   IGHJ3*02 [8.8.16]  IGHG1   CH1 L IGLV1-40*01 IGLJ2*01 or IGLJ3*01 or IGLJ3*02 or IGLJ7*01 [9.3.10]  IGLC3 
Cle 1lil               A IGLV3-1*01 IGLJ2*01 or IGLJ3*01 [6.3.10]  IGLC2 
1lil   B
Hil 8fab B IGHV3-33*01 or IGHV3-33*04   IGHJ4*01 or IGHJ4*02 or IGHJ4*03 [8.8.14]  IGHG1   CH1 A IGLV3-25*02 IGLJ3*02 [6.3.9]  IGLC2 
8fab D IGHV3-33*01 or IGHV3-33*04   IGHJ4*01 or IGHJ4*02 or IGHJ4*03 [8.8.14]  IGHG1   CH1 C
Jto 1cd0               A IGLV6-57*01 IGLJ2*01 or IGLJ3*01 [8.3.9]   
1cd0   B
Kol 2fb4 H IGHV3-33*01 or IGHV3-33*04   IGHJ6*01 or IGHJ6*02 [8.8.19]  IGHG1   CH1 L IGLV1-44*01 IGLJ1*01 [8.3.11]  IGLC1 
2ig2 H IGHV3-33*01 or IGHV3-33*04   IGHJ6*01 or IGHJ6*02 [8.8.19]  IGHG1   CH1 CH2 L
Loc 1bjm               A IGLV1-44*01 IGLJ1*01 [8.3.11]  IGLC1 
1bjm   B
3bjl   A
3bjl   B
4bjl   A
4bjl   B
Loi 2loi               A IGLV3-21*01 IGLJ2*01 or IGLJ3*01 [6.3.11]   
2loi   B
M3C65 1dl7 H IGHV4-59*01   IGHJ4*01 or IGHJ4*02 or IGHJ4*03 [8.7.7]      L IGLV7-43*01 or IGLV7-46*01 IGLJ3*02 [9.3.9]   
Mcg-Weir Hybrid 1mcw               M IGLV2-8*01 IGLJ1*01 [9.3.10]  IGLC1 
1mcw   W IGLV2-23*02 IGLJ6*01 [9.3.10]  IGLC1 
Mcg 1a8j               H IGLV2-8*01 IGLJ1*01 [9.3.10]  IGLC1 
1a8j   L
1dcl   A
1dcl   B
1mcb   A
1mcb   B
1mcc   A
1mcc   B
1mcd   A
1mcd   B
1mce   A
1mce   B
1mcf   A
1mcf   B
1mch   A
1mch   B
1mci   A
1mci   B
1mcj   A
1mcj   B
1mck   A
1mck   B
1mcl   A
1mcl   B
1mcn   A
1mcn   B
1mco H IGHV4-39*01 or IGHV4-39*06   IGHJ5*02 [10.7.9]  IGHG1   CH1 CH2 CH3 L
1mcq               A
1mcq   B
1mcr   A
1mcr   B
1mcs   A
1mcs   B
2mcg   1
2mcg   2
3mcg   1
3mcg   2
Newm 7fab H IGHV4-59*04   IGHJ6*01 or IGHJ6*02 [8.7.11]  IGHG1   CH1 L IGLV1-40*01 IGLJ2*01 or IGLJ3*01 or IGLJ3*02 [9.3.9]  IGLC3 
Rf-An 1adq H IGHV3-9*01   IGHJ4*01 or IGHJ4*02 or IGHJ4*03 [8.8.16]  IGHM   CH1 L IGLV3-21*02 IGLJ2*01 or IGLJ3*01 or IGLJ3*02 or IGLJ7*01 [6.3.11]  IGLC3 
Rhe 2rhe               undefined IGLV1-36*01 IGLJ2*01 or IGLJ3*01 or IGLJ3*02 [8.3.11]   
Wil 2cd0               A IGLV6-57*01 IGLJ2*01 or IGLJ3*01 or IGLJ3*02 [8.3.9]   
2cd0   B

We thank Olga Posukh for her work in the gene and allele identification.


Created: 11/06/2001
Last updated: Monday, 11-Jul-2011 12:56:57 CEST
Author: Manuel Ruiz

Software material and data coming from IMGT server may be used for academic research only, provided that it is referred to IMGT®, and cited as "IMGT®, the international ImMunoGeneTics information system® http://www.imgt.org (founder and director: Marie-Paule Lefranc, Montpellier, France)." References to cite: Lefranc, M.-P. et al., Nucleic Acids Res., 27:209-212 (1999); doi: 10.1093/nar/27.1.209 Full text Cover; Ruiz, M. et al., Nucleic Acids Res., 28:219-221 (2000); doi: 10.1093/nar/28.1.219 Full text; Lefranc, M.-P., Nucleic Acids Res., 29:207-209 (2001); doi: 10.1093/nar/29.1.207 Full text; Lefranc, M.-P., Nucleic Acids Res., 31:307-310 (2003); doi: 10.1093/nar/gkg085 Full text; Lefranc, M.-P. et al., In Silico Biol., 5, 0006 (2004) [Epub], 5:45-60 (2005); Lefranc, M.-P. et al., Nucleic Acids Res., 33:D593-597 (2005); doi: 10.1093/nar/gki065 Full text; Lefranc, M.-P. et al., Nucleic Acids Res., 37:D1006-1012 (2009); doi: 10.1093/nar/gkn838 Full text; Lefranc, M.-P. et al., Nucleic Acids Res., 43:D413-422 (2015); doi: 10.1093/nar/gku1056 Full text.
For any other use please contact Marie-Paule Lefranc Marie-Paule.Lefranc@igh.cnrs.fr.

CNRS Université de Montpellier European Commission
IMGT® Founder and Executive Director Emeritus:
Marie-Paule Lefranc Marie-Paule.Lefranc@igh.cnrs.fr
IMGT® Director:
Sofia Kossida Sofia.Kossida@igh.cnrs.fr
Bioinformatics manager:
Véronique Giudicelli Veronique.Giudicelli@igh.cnrs.fr
Computer manager:
Patrice Duroux Patrice.Duroux@igh.cnrs.fr
Webmaster:
Amélie Houles

Citing IMGT | Warranty disclaimer and copyright notice | Privacy policy and advertisement policy

© Copyright 1995-2017 IMGT®, the international ImMunoGeneTics information system®